| Literature DB >> 22550397 |
Alexander Kaever1, Manuel Landesfeind, Mareike Possienke, Kirstin Feussner, Ivo Feussner, Peter Meinicke.
Abstract
Statistical ranking, filtering, adduct detection, isotope correction, and molecular formula calculation are essential tasks in processing mass spectrometry data in metabolomics studies. In order to obtain high-quality data sets, a framework which incorporates all these methods is required. We present the MarVis-Filter software, which provides well-established and specialized methods for processing mass spectrometry data. For the task of ranking and filtering multivariate intensity profiles, MarVis-Filter provides the ANOVA and Kruskal-Wallis tests with adjustment for multiple hypothesis testing. Adduct and isotope correction are based on a novel algorithm which takes the similarity of intensity profiles into account and allows user-defined ionization rules. The molecular formula calculation utilizes the results of the adduct and isotope correction. For a comprehensive analysis, MarVis-Filter provides an interactive interface to combine data sets deriving from positive and negative ionization mode. The software is exemplarily applied in a metabolic case study, where octadecanoids could be identified as markers for wounding in plants.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22550397 PMCID: PMC3328170 DOI: 10.1155/2012/263910
Source DB: PubMed Journal: J Biomed Biotechnol ISSN: 1110-7243
Figure 1The main window of MarVis-Filter after data import and ranking. The “Ranking plot” (1) displays the adjusted P values (y-axis) of all candidate intensity profiles. The “Profile plot” (2) shows the raw intensity profile of the currently selected marker candidate. The “Marker listbox” (3) displays information about the current marker candidate. The “Data set clipboard listbox” (4) shows data sets which are currently held in the MarVis clipboard.
List of adduct rules for correction of data measured in negative ionization mode.
| Rule | Description | Rule |
|---|---|---|
| 1 | Deprotonation | [ |
| 2 | Formate adduct | [ |
| 3 | Formate adduct with sodium | [ |
List of adduct rules for correction of data measured in positive ionization mode.
| Rule | Description | Rule |
|---|---|---|
| 1 | Protonation | [ |
| 2 | Ammonium adduct | [ |
| 3 | Sodium adduct | [ |
Overview on data sets from the metabolomic case study for plant wounding experiments. The columns “Candidates” and “Filtered candidates” contain the number of marker candidates in the raw data set and the number of significant candidates in the filtered data set, respectively.
| Data set | Ionization | Candidates | Filtered candidates | Samples per condition |
|---|---|---|---|---|
| 1 | Negative | 24796 | 1719 | 9 |
| 2 | Positive | 23325 | 1785 | 9 |
Figure 2Prototype plot of the filtered and combined data in MarVis-Cluster using 30 prototypes for clustering. Every column represents the average intensity profile (prototype) of associated marker candidates. The prototypes are ordered according to similarity based on a one-dimensional self-organizing map. The first prototypes represent marker candidates in a WT-specific wound time course (high intensities in the first four conditions and almost no intensities in the last four conditions).
Identified metabolites in the combined and filtered data set. The retention time is measured in minutes and the exact compound mass is stated in Dalton. The columns “Negative” and “Positive” contain the number of associated marker candidates/ions obtained in the negative or positive ionization mode. The column “Ions” contains the sum of associated marker candidates/ions per compound. The column “P value” contains the minimal adjusted P value of the Kruskal-Wallis test over all associated marker candidates, respectively. The column “Mass error” contains the absolute difference between the corrected mass of the marker candidate with the minimal adjusted P value and the exact compound mass in Dalton.
| RT | Exact mass | Mass error | Name | Formula | Ions | Negative | Positive |
|
|---|---|---|---|---|---|---|---|---|
| 0.73 | 210.1256 | 0.0015 | Jasmonic acid | C12H18O3 | 5 | 5 | 0 | 6.67 |
| 2.08 | 292.2038 | 0.0021 | OPDA | C18H28O3 | 8 | 4 | 4 | 3.41 |
| 1.85 | 310.2144 | 0.0016 | 13-HPOT | C18H30O4 | 1 | 1 | 0 | 2.04 |
| 2.49 | 292.2038 | 0.0027 | 13-KOT | C18H28O3 | 4 | 4 | 0 | 1.70 |
| 1.33 | 264.1725 | 0.0037 | dn-OPDA | C16H24O3 | 5 | 3 | 2 | 7.65 |
| 0.5 | 226.1205 | 0.0009 | 11/12-Hydroxy jasmonic acid | C12H18O4 | 4 | 4 | 0 | 2.87 |
| 0.51 | 339.2046 | 0.0008 | 12-Hydroxy jasmonoyl isoleucine | C18H29NO5 | 1 | 1 | 0 | 3.44 |
| 0.51 | 353.1838 | 0.001 | 12-Carboxy jasmonoyl isoleucine | C18H27NO6 | 1 | 1 | 0 | 2.20 |
| 4.02 | 760.4762 | 0.005 | 18 : 3/dn-OPDA-MGDG | C43H68O11 | 4 | 0 | 4 | 1.96 |
| 2.85 | 774.4554 | 0.0022 | OPDA/dn-OPDA-MGDG | C43H66O12 | 8 | 0 | 8 | 1.93 |
| 3.26 | 802.4867 | 0.0034 | OPDA/OPDA-MGDG | C45H70O12 | 7 | 0 | 7 | 1.79 |
| 4.59 | 1048.6487 | 0.0033 | OPDA/dn-OPDA-MGDG-OPDA | C61H92O14 | 9 | 0 | 9 | 1.48 |
| 4.89 | 1076.68 | 0.002 | OPDA/OPDA-MGDG-OPDA | C63H96O14 | 8 | 0 | 8 | 2.13 |
| 2.36 | 936.5083 | 0.0023 | OPDA/dn-OPDA-DGDG | C49H76O17 | 4 | 0 | 4 | 1.86 |
| 2.76 | 964.5396 | 0.0021 | OPDA/OPDA-DGDG | C51H80O17 | 6 | 0 | 6 | 1.98 |
The identified oxylipins are found in literature under the following synonyms: Jasmonic acid (3-Oxo-2R-(2Z)2-penten-1R-yl-cyclopentaneacetic acid), OPDA (12-Oxo-10,15(Z)-phytodienoic acid or 4-Oxo-5α-(2(Z)-pentenyl)-2-cyclopentene-1α-octanoic acid), 13-HPOT (13-Hydroperoxy-octadeca-9(Z),11(Z),15(Z)-trienoic acid), 13-KOT (13-Keto-octadeca-9(Z),11(Z),15(Z)-trienoic acid), dn-OPDA (4-Oxo-5S-(2Z)-2-penten-1-yl-2-cyclopentene-1S-hexanoic acid), 18 : 3/dn-OPDA-MGDG (Arabidopside F, Monogalactosyldiacylglycerol), OPDA/dn-OPDA-MGDG (Arabidopside A, Monogalactosyldiacylglycerol), OPDA/OPDA-MGDG (Arabidopside B, Monogalactosyldiacylglycerol), OPDA/dn-OPDA-MGDG-OPDA (Arabidopside E, Acylated Monogalactosyldiacylglycerol), OPDA/OPDA-MGDG-OPDA (Arabidopside G, Acylated Monogalactosyldiacylglycerol), OPDA/dn-OPDA-DGDG (Arabidopside C, Digalactosyldiacylglycerol), and OPDA/OPDA-DGDG (Arabidopside D, Digalactosyldiacylglycerol).